Miniatura

Fitxers

1359.pdf (265.35 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-04-18

Llicència de publicació

cc by-nc-nd (c) Kliemann, Nathalie et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/188903

Metabolically-Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1158/1055-9965.EPI-22-0160

Resum

Background: Obesity is a risk factor for endometrial cancer but whether metabolic dysfunction is associated with endometrial cancer independent of body size is not known. Methods: The association of metabolically defined body size phenotypes with endometrial cancer risk was investigated in a nested case-control study (817 cases/ 817 controls) within the European Prospective Investigation into Cancer and Nutrition (EPIC). Concentrations of C-peptide were used to define metabolically healthy (MH; < 1st tertile) and metabolically unhealthy (MU; >_1st tertile) status among the control participants. These metabolic health definitions were combined with normal weight (NW); body mass index (BMI)< 25 kg/m2 or waist circumference (WC)< 80 cm or waist-to-hip ratio (WHR)< 0.8) and overweight (OW; BMI >_25 kg/m2 or WC >_80 cm or WHR >_0. 8) status, generating four phenotype groups for each anthropometric measure: (i) MH/NW, (ii) MH/OW, (iii) MU/ NW, and (iv) MU/OW. Results: In a multivariable-adjusted conditional logistic regression model, compared with MH/NW individuals, endometrial cancer risk was higher among those classified as MU/NW [ORWC, 1.48; 95% confidence interval (CI), 1.05-2.10 and ORWHR, 1.68; 95% CI, 1.21- 2.35] and MU/OW (ORBMI, 2.38; 95% CI, 1.73-3.27; ORWC, 2.69; 95% CI, 1.92-3.77 and ORWHR, 1.83; 95% CI, 1.32-2.54). MH/OW individuals were also at increased endometrial cancer risk compared with MH/NW individuals (ORWC, 1.94; 95% CI, 1.24-3.04). Conclusions: Women with metabolic dysfunction appear to have higher risk of endometrial cancer regardless of their body size. However, OW status raises endometrial cancer risk even among women with lower insulin levels, suggesting that obesity related pathways are relevant for the development of this cancer beyond insulin. Impact: Classifying women by metabolic health may be of greater utility in identifying those at higher risk for endometrial cancer than anthropometry per se.

Matèries

Càncer d'endometri, Trastorns del metabolisme, Obesitat, Factores de riesgo en enfermedades

Matèries (anglès)

Endometrial cancer, Disorders of metabolism, Obesity, Risk factors in diseases

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

KLIEMANN, Nathalie, OULD AMMAR, Romain, BIESSY, Carine, GICQUIAU, Audrey, KATZKE, Verena, KAAKS, Rudolf, TJØNNELAND, Anne, OLSEN, Anja, SÁNCHEZ, Maria jose, CROU BOU, Marta, PASANISI, Fabrizio, TIN TIN, Sandar, PÉREZ CORNAGO, Aurora, AUNE, Dagfinn, CHRISTAKOUDI, Sofia, HEATH, Alicia k., COLORADO-YOHAR, Sandra, GRIONI, Sara, SKEIE, Guri, SARTOR, Hanna, IDAHL, Annika, RYLANDER, Charlotta, MAY, Anne m., WEIDERPASS, Elisabete, FREISLING, Heinz, PLAYDON, Mary c., RINALDI, Sabina, MURPHY, Neil, HUYBRECHTS, Inge, DOSSUS, Laure, GUNTER, Marc j.. Metabolically-Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). _Cancer Epidemiology_. Biomarkers & Prevention. Vol.  2022, núm. 31, pàgs. 7. [consulta: 7 de febrer de 2026]. ISSN: 1538-7755. [Disponible a: https://hdl.handle.net/2445/188903]

Exportar metadades

JSON - METS

Compartir registre